United Therapeutics Corp vs Eli Lilly & Co.
UTHR vs LLY — side-by-side comparison from reported financials. UTHR leads 4, LLY leads 7 of 11 comparable metrics.
United Therapeutics Corp
UTHR · Healthcare
$549.16+3.07%Strong
Eli Lilly & Co.
LLY · Healthcare
$1 177.20+0.65%Solid
| Metric | UTHR | LLY |
|---|---|---|
| Price | $549.16 | $1 177.20 |
| Market cap | $23.6B | $1.05T |
| Revenue (TTM) | $3.15B | $79.7B |
| Revenue growth | +18.0% | +31.7% |
| Net margin | 41.6% | 33.5% |
| Free cash flow | $1.09B | $18.2B |
| Net cash (debt) | $2.88B | ($35.2B) |
| 1-year price return | +23.3% | +37.6% |
| P/E | 18.0 | 41.6 |
| P/E vs own history (cheap-side %) | 26% | 88% |
| Dividend yield | — | 0.52% |
| Return on equity | 20% | 93% |
| Altman Z-score | 21.46 | 7.10 |
| CV checks passed | 10 of 10 | 11 of 10 |
| Employees | 1,400 | 50,000 |
Full résumé-style profiles: UTHR CV · LLY CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.